Regarding lactation, limited data are available on tirzepatide use during breastfeeding
Unlike Shulgin or Baudelaires experiments, retatrutide is not psychoactive
But a growing body of research, and a wave of real-world experience, suggests these drugs may have meaningful benefits for people with T1D too: lower daily insulin doses, flatter glucose curves on your CGM, and potentially better long-term protection for your heart and kidneys
They emphasize rigorous batch testing, meticulous documentation, and a commitment to patient safety
No insurance is required, and treatment is HSA/FSA eligible
They can help assess whether dosing adjustments, meal composition changes, or other factors might be worth exploring based on your individual situation